BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen ...
Palladyne™continues expansion of its domestic and international initiatives with Draganfly to collectively bring trusted UAS platforms with ...
But Bianchi claims the Arcadex AL’s ‘premium aluminium’ outperforms rival metal frames. Using stronger 6069 tubing instead of ...
CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- VelocityEHS, the global leader in EHS solutions and a pioneer in practical, human-centered AI for workplace safety, today announced new AI-powered ...
The Festival of Accord Dreamspell event will bring lots of new armor sets to Monster Hunter Wilds, as well as a fresh ...
Enterprise AI keeps hitting the same wall - not enough people who know how to use it. Databricks is spending $10 million to ...
Scientists that won an infamous 2024 IgNobel Prize for "discovering that many mammals are capable of breathing through their ...
Eight artificial intelligence and machine-learning startups will take the stage Oct. 29 in Bentonville for the 2025 Fuel ...
For years, we believed the Himalayas were a climatic sanctuary—untouched, pristine, and resilient to the turbulence of ...
Adding apalutamide (Erleada) to androgen deprivation therapy (ADT) in patients with biochemically recurrent prostate cancer reduced the risk of developing metastases and castration-resistant disease, ...
AIOps isn’t just a buzzword — it helps teams predict issues before they happen and fix them automatically with smart, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback